No Need To Change Regs To Suit Nanotech Drugs: FDA Official
A U.S. Food and Drug Administration official said Thursday she believed the agency could adequately evaluate drugs containing nanotechnology under the current regulatory framework, though she emphasized that more government research...To view the full article, register now.
Already a subscriber? Click here to view full article